Rankings / Longevity — Supplements

NAD+ / NMN / NR

Longevity · NAD+ precursor

Also known as: Nicotinamide mononucleotide ·Nicotinamide riboside ·Niagen

Tier B+

nad+otc
7.1 / 10
Tier B+
Ev 6 Bn 5 Sf 9

Bottom line

Read Off Label grades NAD+ / NMN / NR as B+ (7.1/10) based on moderate evidence, variable benefit magnitude, and a low-risk safety profile.

Yoshino 2021: NMN 250 mg/day improved muscle insulin sensitivity 25% in prediabetic women.

Typical use: 250-1000 mg/day NMN or NR (sublingual or oral); IV NAD+ infusions also used — OTC.

What this is

Yoshino 2021: NMN 250 mg/day improved muscle insulin sensitivity 25% in prediabetic women. Multiple RCTs show elevated NAD+ but inconsistent functional outcomes (strength, cognition, CV markers). Boosting NAD+ is easy; demonstrating clinical benefit is not.

Mechanism

Precursors to NAD+ — essential cofactor for sirtuins (SIRT1-7), PARPs, CD38; ETC; cellular NAD+ declines with age

Dose & route

250-1000 mg/day NMN or NR (sublingual or oral); IV NAD+ infusions also used

Common questions

Does NAD+ / NMN / NR work?
Read Off Label rates the evidence for NAD+ / NMN / NR as Moderate and the benefit magnitude as variable, producing an overall grade of B+ (7.1/10). Yoshino 2021: NMN 250 mg/day improved muscle insulin sensitivity 25% in prediabetic women.
Is NAD+ / NMN / NR safe?
NAD+ / NMN / NR has a low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for NAD+ / NMN / NR?
250-1000 mg/day NMN or NR (sublingual or oral); IV NAD+ infusions also used
How does NAD+ / NMN / NR work?
Precursors to NAD+ — essential cofactor for sirtuins (SIRT1-7), PARPs, CD38; ETC; cellular NAD+ declines with age

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.